N/A
N=51
Two Phase Clinical Study of the Impact of Contact Lenses and Solutions on Corneal Structure
Normal Contact Lens Wear
Bottom Line
View on ClinicalTrials.gov: NCT00804999 ↗Enrolled (actual)
51
Serious AEs
0.0%
Results posted
Jan 2018
Primary outcome: Primary: HRT Corneal Scan — 85; 66; 49; 63 cells/mm^3
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Clear Care (Drug); ReNu (Drug); OPTI-FREE (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Christine Sindt
- Primary completion
- Mar 2009
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY HRT Corneal Scan |
85; 66; 49; 63; 87; 65 | — |
Summary
Assess the usefulness of using confocal microscopy to examine changes to the structure of the cornea and to identify any potential consequences of contact lens wear and/or solution use.
Eligibility Criteria
Inclusion Criteria
- Vision correctable to 20/30 or better in both eyes
- Successful soft contact lens wear for at least 2 weeks prior to enrollment
Exclusion Criteria
- History of hypersensitivity to any of the components in any of the lens solutions
- One functional eye or a monofit lens
- Any abnormal slit-lamp finding at baseline
- Use of topical ocular meds
- Any systemic condition with significant ocular side effects or that interfere with contact lens wear
- Enrollment of the investigator's office staff, relatives or members of their respective households
- Enrollment of more than one member of the same household
Data sourced from ClinicalTrials.gov (NCT00804999). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.